Khosla Impact

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Principal

Peter Buckland

General Partner and COO

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding Partner and Managing Director

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Evan Moore

Partner

Alexander Morgan

Partner

Nicholas Moryl

Associate

Keith Rabois

Managing Director

Arash Rebek

Partner, Capital Formation

Jessy Rivest

Partner and Investor

Jai Sajnani

Partner

Jai Sajnani

Partner and Investor

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner

David Weiden

Managing Director

Reze Wong

Partner

Adam Coates

Operating Partner

Kanupriya Gulati Ph.D

Partner and Investor

Past deals in Machine Learning

Cognition

Venture Round in 2025
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.

Danswer

Seed Round in 2025
Danswer is an AI-powered assistant that helps companies efficiently locate information by integrating seamlessly with their tools and documents. The company specializes in creating custom answer bots tailored to the specific needs of different teams, utilizing advanced embedding models alongside keyword-based algorithms. This technology allows Danswer's clients to access relevant documents across various sources, streamlining the process of finding necessary information without unnecessary complexity. By providing a user-friendly interface, Danswer aims to enhance productivity and facilitate better decision-making within organizations.

Nomagic

Series B in 2025
Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Regie.ai

Series B in 2025
Regie.ai is a developer of an AI-powered platform that focuses on enhancing sales engagement and automating outbound prospecting. Its product, RegieOne, combines various functionalities such as sales engagement, parallel dialing, data enrichment, and intent analysis, allowing operations teams to manage their processes efficiently from a centralized interface. Additionally, Regie.ai's platform facilitates the creation, testing, and analysis of personalized sales campaigns, thereby improving engagement and optimizing the performance of frontline sales teams. Through its innovative approach, Regie.ai aims to streamline sales workflows and drive better outcomes for businesses.

Speak

Series C in 2024
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.

Moonvalley

Seed Round in 2024
Moonvalley builds creative studio, powered by the most capable video and image foundational models. The company is creating the place where generative image and video experiences will be built. Backed by Y-Combinator and Khosla Ventures.

Physical Intelligence

Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

Genie AI

Series A in 2024
Genie AI Limited is a company based in London, United Kingdom, that specializes in artificial intelligence solutions for the legal sector. It has developed a platform called SuperDrafter, which utilizes machine learning to assist lawyers in drafting contracts more efficiently by leveraging the collective knowledge of their firm. Additionally, Genie AI offers a feature known as Anonymiser that automatically redacts sensitive information from contracts. The company also organizes educational events and training sessions focused on smart contracts and the application of artificial intelligence in legal practices. Founded in 2017, Genie AI aims to enhance the contract drafting process, allowing lawyers to manage client risks and negotiate effectively within tight deadlines.

OpenAI

Venture Round in 2024
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

Distyl

Series A in 2024
Distyl AI specializes in helping organizations enhance their readiness for artificial intelligence by developing customized AI solutions that align with their specific data, workflows, and workforce needs. The company offers a generative AI solutions platform that supports major institutions in adopting foundational models and preparing for AI integration. By collaborating with leading organizations globally, Distyl AI aims to create reliable and seamlessly integrated AI-driven services, enabling enterprises to thrive in an increasingly AI-assisted economy.

Vanan Online Services

Series B in 2024
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.

Inflammatix

Series E in 2024
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By leveraging self-supervised learning and integrating human multimodal data, the company aims to enhance the effectiveness and personalization of cancer therapies, thereby improving patient outcomes in oncology.

Speak

Series B in 2024
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.

Waabi

Series B in 2024
Waabi is an artificial intelligence company based in Toronto, Canada, focused on developing autonomous driving technology for the transportation sector. Founded in 2021 by Raquel Urtasun, Waabi offers a self-driving solution called the Waabi Driver, specifically designed for integration with trucks. The company's technology aims to facilitate large-scale commercialization and safe deployment of autonomous vehicles in the logistics and transportation industries. By utilizing advanced deep learning, probabilistic inference, and complex optimization techniques, Waabi's software is capable of complex reasoning and is end-to-end trainable. This approach allows clients to test driving scenarios and safety-critical edge cases in a closed-loop simulator, significantly reducing the need for extensive real-world testing and enhancing safety and cost-effectiveness in the deployment of autonomous trucking solutions.

PolyAI

Series C in 2024
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.

Cognition

Series A in 2024
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.

Collaborative Robotics

Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Symbolica AI

Series A in 2024
Symbolica AI is a research-driven company that develops a unique business model platform. This platform leverages geometric and topological principles in machine learning to train models using formal computational logic, rather than traditional statistical methods. The result is enhanced decision-making capabilities for clients, fostering business growth.

Physical Intelligence

Seed Round in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

Limbic

Series A in 2024
Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Raspberry AI

Seed Round in 2024
Raspberry AI employs artificial intelligence technology to design styles that are in high demand. The platform offers the convenience of instantly generating technical packs and CADs for any product image, providing a comprehensive solution for product design requirements. It also features automated, high-conversion product descriptions and photography, along with the capability to create new high-fidelity designs from a sketch or reference image.

Recraft

Series A in 2024
Recraft is a creative AI tool.

Sakana AI

Seed Round in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Agrawal's AI initiative

Seed Round in 2024
Agrawal's AI initiative operates as an AI company to create software for LLM developers. Parag Agrawal formerly held the position of Twitter's CEO before Elon Musk's takeover now venturing into artificial intelligence as the venture's name and product details have not been revealed.

Sarvam AI

Series A in 2023
Sarvam AI focuses on advancing artificial intelligence research to enhance the performance, reliability, and affordability of generative AI application development in India. The company develops sophisticated large language models tailored to the country's diverse linguistic environment, providing a user-friendly platform for creating and assessing generative AI applications. Sarvam AI emphasizes open-source collaboration, allowing businesses to leverage modern AI technology to gain a competitive advantage in their respective markets.

Kognitos

Series A in 2023
Kognitos is an AI platform that focuses on automating business processes to enhance operational efficiency. Founded in 2021 and headquartered in San Jose, California, Kognitos provides software that simplifies daily business operations. Its platform allows users to manage complex end-to-end processes through straightforward English commands, making automation accessible and user-friendly. This approach enables businesses to scale effectively with minimal initial investment, streamlining workflows and increasing productivity.

Astrus

Seed Round in 2023
Operator of an artificial intelligence-powered analog layout automation platform intended to improve the computation speed. The company's platform uses deep-reinforces learning and planning to take the schematics and generate analog layouts, enabling circuit designers to generate quality layouts rapidly and efficiently.

Coframe

Seed Round in 2023
Coframe is a technology company that specializes in AI-driven A/B testing and personalization for websites and applications. Its platform continuously analyzes user interactions to optimize content, improving user experience, engagement, and conversion rates. Coframe's solution involves training multimodal models to understand user behavior and business goals, enabling user interfaces to autonomously enhance themselves over time.

Vayu Robotics

Seed Round in 2023
Vayu Robotics is an AI robotics company that focuses on developing and commercializing advanced robotics technology for autonomous systems. The company creates a scalable mobile robotics platform that leverages bio-inspired sensing and machine learning to deliver low-cost, environmentally sustainable, and highly adaptable autonomous solutions. By integrating purposeful robotic design, Vayu Robotics aims to enhance the capabilities of automotive sensing and autonomous vehicles, providing users with innovative tools for a variety of applications in the robotics industry.

Ello

Series A in 2023
Ello focuses on transforming children's reading experiences by integrating artificial intelligence with traditional books, thereby providing personalized learning through evidence-based reading instruction. The company aims to assist children who encounter difficulties while reading and employs behavioral psychology techniques to encourage continued engagement with the material. By fostering a personal connection with real books, Ello seeks to nurture children's natural curiosity and cultivate a lifelong love for learning. Through its innovative approach, Ello positions itself as a leader in the educational technology space, dedicated to enhancing literacy and making reading a more accessible and enjoyable journey for young learners.

Automat AI

Seed Round in 2023
Automat offers robotic process automation for Chrome using GPT4 and computer vision. With the aid of its LLM automation tools, Automat streamlines procedures and improves operational efficiency.

Collaborative Robotics

Series A in 2023
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Speak

Series B in 2023
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.

Univerbal

Seed Round in 2023
Univerbal is a developer of a conversational language learning tool that enables learners to achieve speaking fluency through dynamic, unscripted conversations on topics of their choice. Utilizing an AI Agent, the platform provides a personalized learning experience by analyzing each user's individual progress and offering tailored feedback and suggestions for improvement. Gamification elements, such as levels, enhance user engagement and motivation, creating a supportive learning environment. By focusing on practical conversational experience from the outset, Univerbal empowers language learners to practice and develop their skills effectively.

Korbit Technologies

Series A in 2023
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, is focused on revolutionizing education through its AI-powered tutor, Korbi. This intelligent platform offers personalized learning experiences by adapting to each student's unique profile, providing interactive exercises, quizzes, visual diagrams, and real-time feedback. Korbi aims to enhance learning outcomes and motivation for students by delivering targeted pedagogical support in areas such as data science and artificial intelligence. The company also offers a free machine learning course and serves a diverse clientele, including students, educators, and corporations. With nearly 20,000 learners benefiting from its training programs, Korbit has gained recognition as one of the top AI startups globally, supported by partnerships with institutions like Mila, and has received media coverage from prominent outlets such as the New York Times and Forbes.

Fulfil Solutions

Series B in 2023
Fulfil Solutions specializes in developing custom robotic automation technology aimed at enhancing the online grocery supply chain. The company focuses on creating fully automated fulfillment systems that address various challenges through a combination of mechanical design, software, robotics, computer vision, and deep learning. By enabling efficient picking and packing across all product categories and temperature zones, Fulfil Solutions helps businesses achieve customer-centric and sustainable operations while minimizing labor requirements and space utilization. The company's mission is to reduce waste, environmental impact, and emissions, ultimately making online grocery services more profitable and scalable.

Astrus

Pre Seed Round in 2023
Operator of an artificial intelligence-powered analog layout automation platform intended to improve the computation speed. The company's platform uses deep-reinforces learning and planning to take the schematics and generate analog layouts, enabling circuit designers to generate quality layouts rapidly and efficiently.

Regie.ai

Series A in 2023
Regie.ai is a developer of an AI-powered platform that focuses on enhancing sales engagement and automating outbound prospecting. Its product, RegieOne, combines various functionalities such as sales engagement, parallel dialing, data enrichment, and intent analysis, allowing operations teams to manage their processes efficiently from a centralized interface. Additionally, Regie.ai's platform facilitates the creation, testing, and analysis of personalized sales campaigns, thereby improving engagement and optimizing the performance of frontline sales teams. Through its innovative approach, Regie.ai aims to streamline sales workflows and drive better outcomes for businesses.

Arpeggio Bio

Series A in 2022
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

PolyAI

Series B in 2022
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.

Collaborative Robotics

Seed Round in 2022
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics is focused on developing innovative medicines using advanced 3D deep learning and drug discovery technologies. The company's platform aims to address undruggable disease targets, providing healthcare professionals with effective treatment options for challenging medical conditions. By leveraging cutting-edge technology, CHARM Therapeutics seeks to create transformative therapies that have the potential to significantly improve patient outcomes.

Anagenex

Series A in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.

Finnt

Seed Round in 2022
Finnt develops automated financial analysis software designed to enhance the efficiency of corporate finance operations. By leveraging artificial intelligence, the software accelerates decision-making processes for financial firms while improving the analytical capabilities of finance teams. It simplifies workflows by eliminating manual and repetitive tasks, allowing users to focus on more strategic activities. Additionally, Finnt's platform supports the establishment of shared savings goals and facilitates tracking of spending habits, enabling individuals to save effectively for family members both domestically and internationally.

Nomagic

Series A in 2022
Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Myko

Seed Round in 2022
Myko AI is an artificial intelligence tool that pulls financial data from spreadsheets and helps make successful revenue-generating decisions with minimum onboarding. The company's application integrates directly into users' existing CRM platforms and chat applications, allowing data to be analyzed in seconds. This enables businesses to drive more revenue by providing their teams with deeper analytical capabilities and improving the financial reporting process by spending less time copying and pasting data.

Anagenex

Seed Round in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.

Fundbox

Series D in 2021
Fundbox, established in 2013, is a financial technology company based in San Francisco, California, with an additional office in Plano, Texas. It operates an AI-driven platform that provides credit and payment solutions to small businesses serving other businesses (SMB2B). Fundbox uses machine learning and deep data analytics to facilitate business payments, offer invoice financing, and provide lines of credit, helping SMEs manage their cash flow more efficiently.

Mimica Automation

Series A in 2021
Mimica Automation Limited, founded in 2018 and based in London, develops innovative software that leverages machine learning algorithms to automate repetitive tasks. By observing user interactions, such as clicks and keystrokes, for a period of two to three weeks, the software derives intent and generates automation solutions automatically. Its key offering, the mapper, gathers data from employees' computers to create a comprehensive process map by analyzing and merging the recorded activities. Backed by Entrepreneur First, a prominent accelerator and seed fund in Europe, Mimica aims to enhance workplace efficiency by simplifying the automation of routine tasks.

Vanan Online Services

Series A in 2021
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.

PolyAI

Series A in 2021
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.

Checkr

Series E in 2021
Checkr, Inc. is a technology-driven company focused on the background check industry, offering a comprehensive range of screening services, including criminal record checks, driving checks, and identity verification. Founded in 2014 and headquartered in San Francisco, California, Checkr utilizes advanced technology and data sources to deliver faster and more efficient background checks compared to traditional providers. The company emphasizes fairness and transparency in hiring, enabling businesses across various sectors, including financial services, healthcare, and staffing, to enhance their hiring processes. Checkr also provides compliance services and security solutions, ensuring a secure and streamlined experience for both employers and candidates. With its innovative platform, Checkr aims to improve the overall applicant experience while supporting companies in navigating the complexities of today's workforce dynamics.

Known Medicine

Seed Round in 2021
Known Medicine Inc., founded in 2020 and based in Salt Lake City, Utah, specializes in developing a custom organoid platform designed for tumor sensitivity testing. The company aims to enhance cancer treatment by conducting experiments on tumor responses to drugs in a controlled laboratory setting rather than within the patient’s body. Known Medicine's innovative approach involves breaking down tumor samples into microtumors, which are treated in specialized micro-environments using various methods to identify the most effective treatments. The platform utilizes machine learning-based sensitivity assays and integrates omics data to detect different cell types, including cancerous, stromal, and immune cells. This enables oncologists to analyze multiple microtumors, ultimately helping to determine optimal treatment strategies for individual patients.

Gaiascope

Seed Round in 2021
Gaiascope, Inc. is a software-as-a-service company based in Brooklyn, New York, founded in 2019, that specializes in developing analytics solutions for the energy sector. The company's software employs machine learning techniques to analyze big data, providing insights into locational marginal pricing, grid constraints, weather patterns, plant dispatch, and energy demand. Gaiascope aims to facilitate the transition to a more sustainable energy future by offering user-friendly tools that promote transparency and practical application over complex algorithms. Its solutions are designed to optimize real-time trading, operations, and development, addressing the complexities of modern power markets, including the integration of renewable energy sources. By utilizing scenario analysis and accurate, probabilistic price forecasts, Gaiascope helps energy companies and investors better understand and navigate the evolving landscape of the electric grid, ultimately enhancing investment opportunities and profitability in the sector.

Berkshire Grey

Post in 2021
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Waabi

Series A in 2021
Waabi is an artificial intelligence company based in Toronto, Canada, focused on developing autonomous driving technology for the transportation sector. Founded in 2021 by Raquel Urtasun, Waabi offers a self-driving solution called the Waabi Driver, specifically designed for integration with trucks. The company's technology aims to facilitate large-scale commercialization and safe deployment of autonomous vehicles in the logistics and transportation industries. By utilizing advanced deep learning, probabilistic inference, and complex optimization techniques, Waabi's software is capable of complex reasoning and is end-to-end trainable. This approach allows clients to test driving scenarios and safety-critical edge cases in a closed-loop simulator, significantly reducing the need for extensive real-world testing and enhancing safety and cost-effectiveness in the deployment of autonomous trucking solutions.

Inflammatix

Series D in 2021
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Lumiata

Series B in 2021
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

WaveOne

Series A in 2020
WaveOne, Inc. specializes in developing advanced video and image compression software utilizing machine learning and artificial intelligence. Founded in 2016 and located in Palo Alto, California, the company focuses on delivering custom, context-dependent solutions that significantly enhance the efficiency of digital media compression. WaveOne's technology features a codec capable of operating orders of magnitude faster than traditional systems, enabling rapid encoding and decoding of data sets at high speeds. This innovation allows digital media industries to process, print, upload, and share clear images effectively, positioning WaveOne at the forefront of digital media compression advancements.

Menten AI

Seed Round in 2020
Menten AI, Inc. is an early-stage drug discovery company based in San Francisco, California, with an additional location in Toronto, Canada. Founded in 2018, the company focuses on developing protein-based drugs and enzymes using advanced technologies, specifically machine learning and quantum computing. Menten AI addresses the complex challenge of designing proteins, which can adopt numerous shapes, by leveraging quantum computing to represent multiple protein states simultaneously. This innovative approach allows for more efficient identification of optimal protein designs. The company has achieved significant milestones, including creating the world’s first peptide designed on a quantum computer, and is currently working on peptide therapeutics aimed at treating oncology and neurodegeneration, as well as enzymes for various industrial applications.

TaxProper

Seed Round in 2020
TaxProper Inc. is a Chicago-based company that develops advanced property tax calculation solutions aimed at assisting homeowners with property tax assessments and appeals. Recognizing that traditional government methods for home valuation are often outdated and imprecise, TaxProper utilizes cutting-edge machine-learning techniques to provide more accurate property valuations. Homeowners can enter details about their properties to determine if they are overpaying on taxes. If an overvaluation is identified, TaxProper's platform automatically generates and files the necessary appeal paperwork, streamlining a process that is typically expensive and confusing. By simplifying the appeals process, TaxProper aims to ensure that homeowners pay a fair amount in property taxes, thereby addressing the imbalance created by inefficient technology in the valuation system.

HeartVista

Series A in 2020
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Its platform leverages existing scanners and contains all of the mri tools needed for a comprehensive cardiac examination, with just one click.

Ello

Seed Round in 2020
Ello focuses on transforming children's reading experiences by integrating artificial intelligence with traditional books, thereby providing personalized learning through evidence-based reading instruction. The company aims to assist children who encounter difficulties while reading and employs behavioral psychology techniques to encourage continued engagement with the material. By fostering a personal connection with real books, Ello seeks to nurture children's natural curiosity and cultivate a lifelong love for learning. Through its innovative approach, Ello positions itself as a leader in the educational technology space, dedicated to enhancing literacy and making reading a more accessible and enjoyable journey for young learners.

Rosebud AI

Seed Round in 2020
Rosebud AI, Inc. is a San Francisco-based company that specializes in developing software for creating digital avatars and models tailored for various uses. The platform allows users to customize avatars based on demographic factors, age, and style, making it accessible for a wide range of applications. Additionally, Rosebud AI focuses on generating artificial intelligence-driven game assets, simplifying the process of visual content creation for creators. The software enables users to effortlessly produce non-fungible token (NFT) collections without requiring prior experience in smart contracts or web3 technologies. By integrating established computer graphics techniques with advanced AI research, the company also offers tools for animating old photos and enhancing artistic creations, thereby enriching the digital content landscape.

iMerit

Series B in 2020
iMerit is a prominent AI data solutions provider focused on delivering high-quality data for machine learning and artificial intelligence applications. The company specializes in data labeling technologies and services across various industries, including agricultural AI, autonomous vehicles, commerce, geospatial, government, financial services, and medical AI. Headquartered in San Jose, California, iMerit operates large teams dedicated to computer vision and natural language processing in India, the United States, Bhutan, and Europe. Founded by Radha Basu, iMerit employs over 5,000 full-time staff, with more than half being women, reflecting its commitment to diversity. The company serves numerous Fortune 500 clients, helping them achieve optimal results from their algorithms through enriched and accurately labeled data.

Nomagic

Seed Round in 2020
Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Arpeggio Bio

Seed Round in 2020
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

Inflammatix

Series C in 2020
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Ghost Autonomy

Series C in 2019
Ghost Autonomy is focused on making self-driving technology accessible to the consumer car market. The company develops a software-defined autonomous driving platform that leverages advancements in artificial intelligence to ensure highway autonomy is both safe and scalable. Its platform includes AI-enabled software that encompasses a perception system, planning and decision-making algorithms, and vehicle control software. This comprehensive offering allows automakers and suppliers to integrate autonomous driving capabilities into their vehicles efficiently, minimizing the need for extensive hardware modifications. Through its innovative approach, Ghost aims to facilitate the widespread adoption of autonomous driving technology in everyday vehicles.

Vanan Online Services

Seed Round in 2019
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.

Korbit Technologies

Seed Round in 2019
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, is focused on revolutionizing education through its AI-powered tutor, Korbi. This intelligent platform offers personalized learning experiences by adapting to each student's unique profile, providing interactive exercises, quizzes, visual diagrams, and real-time feedback. Korbi aims to enhance learning outcomes and motivation for students by delivering targeted pedagogical support in areas such as data science and artificial intelligence. The company also offers a free machine learning course and serves a diverse clientele, including students, educators, and corporations. With nearly 20,000 learners benefiting from its training programs, Korbit has gained recognition as one of the top AI startups globally, supported by partnerships with institutions like Mila, and has received media coverage from prominent outlets such as the New York Times and Forbes.

Fundbox

Series C in 2019
Fundbox, established in 2013, is a financial technology company based in San Francisco, California, with an additional office in Plano, Texas. It operates an AI-driven platform that provides credit and payment solutions to small businesses serving other businesses (SMB2B). Fundbox uses machine learning and deep data analytics to facilitate business payments, offer invoice financing, and provide lines of credit, helping SMEs manage their cash flow more efficiently.

Vanan Online Services

Seed Round in 2019
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.

OpenAI

Corporate Round in 2019
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

Abacus.AI

Seed Round in 2019
Abacus.AI, Inc. is a San Francisco-based company that specializes in cloud-based artificial intelligence services. Founded in 2019, it focuses on helping organizations design, train, and implement machine and deep learning models tailored to various business needs. The company's platform enables businesses to integrate customizable deep learning systems into their existing processes and customer experiences. Abacus.AI offers a range of solutions, including AI for IT operations, marketing and sales, fraud detection, recommendation systems, forecasting, and predictive modeling. Its autonomous AI platform is designed to support common enterprise applications, such as churn prediction and time-series forecasting, facilitating the creation of state-of-the-art, real-time AI solutions for clients.

OpenAI

Venture Round in 2019
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.

Datera

Series C in 2018
Datera is a developer of a data management platform that simplifies enterprise data storage through automation and machine learning. The company focuses on intelligent placement technology, which allows for effective data orchestration to manage capacity and performance based on application requirements. By partnering with major infrastructure providers such as HPE, Intel, and Cisco, Datera offers a cost-effective solution that reduces total ownership and operational expenses by 70%. Founded by key figures in the development of the Linux I/O storage stack, Datera is supported by prominent investors, including Khosla Ventures and Samsung Ventures.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Remedy

Seed Round in 2018
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.

Ghost Autonomy

Series B in 2018
Ghost Autonomy is focused on making self-driving technology accessible to the consumer car market. The company develops a software-defined autonomous driving platform that leverages advancements in artificial intelligence to ensure highway autonomy is both safe and scalable. Its platform includes AI-enabled software that encompasses a perception system, planning and decision-making algorithms, and vehicle control software. This comprehensive offering allows automakers and suppliers to integrate autonomous driving capabilities into their vehicles efficiently, minimizing the need for extensive hardware modifications. Through its innovative approach, Ghost aims to facilitate the widespread adoption of autonomous driving technology in everyday vehicles.

Lumiata

Series B in 2018
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision Ltd. is a company that develops an imaging analytics platform aimed at enhancing patient care in healthcare institutions. Founded in 2014 and based in Shefayim, Israel, the platform utilizes advanced learning and computer vision algorithms to assist clinicians in identifying patients at risk of various diseases. This technology supports healthcare providers in implementing effective risk management and preventative care strategies. Zebra Medical Vision also supplies tools and datasets for machine-learning researchers, facilitating the rapid development of decision support tools and diagnostic solutions. The company has established strategic partnerships with organizations such as USARAD Holdings and TELUS Ventures, and has secured a total of $52 million in funding from notable investors, including Khosla Ventures and Nvidia. Its AI-driven products are FDA cleared and are utilized in hospitals across multiple regions, including the U.S., Europe, Australia, India, and Latin America, positioning Zebra Medical Vision as a leader in the field of medical imaging and analytics.

Giant.AI

Seed Round in 2018
Giant.ai, Inc., established in 2017 and based in San Francisco, California, focuses on advancing technologies in computer vision, deep learning, and robotics. The company develops intelligent and cost-effective robotic workers designed to complement human labor in low-skill manual tasks across various industries, including manufacturing, agriculture, and logistics. By integrating these robotic solutions, organizations can significantly enhance productivity and improve the overall human condition, facilitating a more efficient workforce in diverse sectors.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company leverages artificial intelligence to provide chat-based primary care services, aiming to make high-quality and affordable healthcare accessible to everyone, anytime. Curai Health's platform integrates clinicians with advanced AI and machine learning tools to create a learning healthcare system that enhances the efficiency and cost-effectiveness of medical care. By facilitating better communication between patients and healthcare professionals, the platform aids in accurate diagnosis and treatment. Curai Health offers its services directly to consumers and through partnerships with enterprises.

Atomwise

Series A in 2018
Atomwise, Inc. is a biotechnology company based in San Francisco that specializes in using deep learning artificial intelligence for small molecule drug discovery. Founded in 2012, Atomwise developed the AtomNet platform, which enables virtual screening of molecules by predicting the binding of small molecules to proteins through a statistical approach that leverages experimental affinity measurements and protein structures. The company focuses on addressing over 600 unique disease targets and has established partnerships with more than 250 organizations, including pharmaceutical and biotechnology firms. Atomwise's technology has been recognized for its ability to unlock previously undruggable targets, and the company has raised significant funding to support its mission of accelerating drug discovery and development.

Bidgely

Series C in 2018
Bidgely, Inc. is a technology company based in Mountain View, California, with an additional office in Bengaluru, India. Founded in 2011, Bidgely specializes in disaggregation-powered utility solutions, enabling utilities to provide detailed appliance-level energy consumption data through its innovative HomeBeat software. Its UtilityAI Platform leverages machine learning algorithms to analyze customer energy habits, delivering actionable insights that enhance energy efficiency and consumer engagement. By itemizing energy usage data without the need for plug-level monitors, Bidgely aims to transform how utilities interact with residential customers, helping them manage energy consumption and peak demand more effectively. The company serves a global market, working with utilities to promote energy savings and improve customer retention.

DiscernDx

Seed Round in 2018
DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.

Replika

Series A in 2017
Luka is a software development company based in San Francisco, California, known for its AI-powered chatbot applications. The company first gained attention with the Luka app, a messenger that facilitates various tasks such as dining suggestions, web searches, and trivia games. In 2016, Luka introduced Replika, an innovative app that allows users to create a personal AI through text conversations. This app utilizes a proprietary deep learning architecture to engage users in meaningful interactions. Replika is designed to recognize individual tone and personality traits, effectively storing memories and adapting to mimic the user's texting style over time. This capability enables users to maintain a conversational journal, fostering a unique and personalized experience.

Lumiata

Series A in 2017
Lumiata Inc. specializes in predictive health analytics tailored for risk-bearing organizations, including hospital networks and insurance carriers. Founded in 2013 and based in San Mateo, California, the company has developed a medical graph that organizes and analyzes diverse healthcare data, enabling real-time predictive analytics. Its flagship product, The Lumiata Risk Matrix, provides personalized predictions regarding individual health changes, supported by a chain of medical reasoning. By leveraging over 120 million patient records and proprietary clinical knowledge, Lumiata's machine learning tools empower healthcare providers and payers to enhance decision-making, manage costs, and improve patient care. The company serves a range of clients, including payers, population health organizations, and digital health companies, facilitating applications in underwriting and care management while prioritizing member privacy.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in developing neuroscience-based assessment and prediction technology aimed at transforming the recruitment, retention, and development of employees. Founded in 2013 and headquartered in New York City, Pymetrics utilizes a combination of neuroscience and machine learning to create a talent matching platform. This platform collects behavioral data from successful professionals across various roles to identify key traits that distinguish top performers from the general population. By offering cognitive and emotional assessment solutions, along with a personalized recommendation engine, Pymetrics enhances the effectiveness and accuracy of the hiring process, while promoting unbiased recruitment practices.

Paravision

Series B in 2017
Paravision is a San Francisco-based company that specializes in developing advanced face recognition software, primarily for security device manufacturers, solution providers, systems integrators, and financial services firms. Founded in 2013 and originally known as Ever AI until its rebranding in 2019, Paravision leverages deep learning to create industry-leading Vision AI solutions. The company's technology enhances security and user experience by offering capabilities such as age, gender, emotion, and ethnicity detection, facilitating personalized customer interactions and improved security measures. Paravision's commitment to innovation is evident in its high rankings in various NIST evaluations, where it has demonstrated exceptional performance in face recognition accuracy, security, and convenience across diverse identity-centric applications worldwide. With a focus on modular and scalable solutions, Paravision aims to set new standards in face recognition technology.

Vicarious

Series C in 2017
Vicarious is an artificial intelligence company founded in 2010 by Dr. Dileep George and D. Scott Phoenix. The company develops neuro and cognitive science-based technologies aimed at creating general intelligence for robots by mimicking the functions of the human brain. Its innovative algorithmic architecture seeks to achieve human-level intelligence in areas such as vision, language, and motor control. Vicarious focuses on visual perception challenges, including recognition, segmentation, and scene parsing. This technology enables robot manufacturers to produce robots with enhanced intelligence and improved task efficiency.

MDalgorithms

Seed Round in 2017
MDalgorithms Inc. is a technology company based in Mountain View, California, founded in 2015. It specializes in developing applications for individuals dealing with acne and other skin disorders. By leveraging artificial intelligence and computer vision, MDalgorithms offers real-time mobile tools that allow users to conduct self-diagnosis and receive personalized treatment plans. The company’s applications analyze users' skin and scalp through selfies, delivering customized treatment kits directly to their homes. Additionally, clients benefit from chat support with a medical team, enhancing the accessibility and personalization of skincare and haircare regimes while shifting focus from traditional physician-centric models to a more patient-centered approach.

Speak

Seed Round in 2017
Speak is an AI-powered language-learning mobile application focused on helping users improve their English skills. The app employs advanced speech recognition technology, allowing users to engage in conversations about real-world scenarios. This approach enables individuals to better understand English words, even when spoken with strong accents, and facilitates a more intuitive learning experience. By providing personalized and interactive lessons, Speak aims to make the process of learning English accessible and efficient for users of varying proficiency levels.

Inflammatix

Series A in 2017
Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

NMLStream

Seed Round in 2017
NMLStream specializes in artificial intelligence solutions for information technology management. The company has developed decision-making software that connects performance monitoring with automated actions. This software leverages AI to automate and predict system behaviors, making it applicable in cloud, on-premises, or hybrid environments. By generating a unified digital language for system behaviors, NMLStream's technology facilitates collaboration across various IT silos. This capability allows businesses to optimize performance and enhance application uptime, ultimately improving overall operational efficiency.

Upstart

Series C in 2017
Upstart is a peer-to-peer online lending platform that utilizes artificial intelligence and machine learning to enhance the lending process. Founded in 2012 and based in San Mateo, California, the company focuses on providing fixed-rate personal loans by employing a proprietary underwriting model that evaluates factors such as education, area of study, and employment history, allowing it to identify borrowers with limited credit backgrounds. Upstart connects consumer loan demand with its network of AI-enabled bank partners, facilitating a streamlined borrowing experience. The platform supports a variety of loan offerings, including personal loans, automotive financing, home equity lines of credit, and small-dollar loans, enabling banks to achieve higher approval rates and reduced loss rates while enhancing customer satisfaction through a digital-first approach.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.